Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular

Mhairi K Sigrist1, Adeera Levin, Lee Er

  • 1School of Graduate Entry Medicine and Health, The University of Nottingham, Derby, UK. msigrist@providencehealth.bc.ca

Insights

Osteoprotegerin (OPG) and vascular calcification predict death in chronic kidney disease (CKD) patients. This study highlights OPG as an independent predictor of mortality, beyond its association with vascular damage.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Cardiovascular disease is the primary cause of mortality in chronic kidney disease (CKD) patients.
  • Mechanisms underlying vascular damage in CKD are not fully elucidated.
  • Vascular calcification (VC) is a known contributor to adverse outcomes in CKD.

Purpose of the Study:

  • To prospectively investigate novel mediators of vascular damage in CKD.
  • To assess the combined impact of vascular calcification and novel mediators on patient survival.
  • To identify predictors of mortality in patients with chronic kidney disease.

Main Methods:

  • 134 CKD patients (60 hemodialysis, 28 peritoneal dialysis, 46 stage 4) were followed for 40 months.
  • Vascular calcification (VC) assessed via CT scan; circulating osteoprotegerin (OPG), Fetuin-A, and hs-CRP measured.
  • Standard clinical and biochemical analyses performed.

Main Results:

  • 31 deaths occurred over 40 months, with all deceased patients exhibiting significant VC.
  • Male gender, elevated OPG levels (>25 pmol/L), and hypoalbuminemia were associated with increased mortality risk.
  • Osteoprotegerin (OPG) emerged as an independent predictor of mortality, irrespective of C-reactive protein (CRP) levels.

Conclusions:

  • Vascular calcification (VC) and low albumin predict death in advanced CKD stages.
  • Osteoprotegerin (OPG) is independently associated with a negative prognosis in CKD patients.
  • Further research is needed to elucidate the mechanisms linking OPG to vascular damage and mortality in CKD.
Abstract

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...